Last 36 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 14.53 | 40.50 | 124.26 | 11.74 | 42.50 | 36.42 | 24.03 | 82.04 | 327.08 | 107.59 | 52.81 | 164.44 | — | — | — | — | — | — | — | — | — |
| — | +11.2% | +417.1% | -85.7% | -87.0% | -66.2% | -54.5% | -50.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 4.04 | 3.56 | 5.17 | 7.74 | 7.95 | 8.63 | 4.68 | 4.51 | 12.88 | 11.62 | 6.62 | 8.31 | 6.72 | 13.02 | 14.70 | 15.74 | 12.28 | 10.72 | 11.85 | 13.76 | 42.67 |
| — | -58.8% | +10.6% | +71.6% | -38.3% | -25.7% | -29.3% | -45.7% | +91.6% | -10.7% | -55.0% | -47.2% | -45.3% | +21.5% | +24.0% | +14.4% | -71.2% | -61.8% | -70.5% | -22.3% | +223.5% | |
| P/B Ratio | 6.07 | 5.22 | 7.28 | 10.52 | 12.87 | 17.09 | 10.08 | 9.60 | 26.69 | 27.99 | 16.08 | 19.66 | 14.12 | 18.82 | 12.68 | 10.54 | 6.72 | 17.28 | 12.57 | 7.84 | 11.67 |
| — | -69.5% | -27.8% | +9.6% | -51.8% | -39.0% | -37.3% | -51.2% | +89.0% | +48.7% | +26.8% | +86.5% | +110.2% | +8.9% | +0.9% | +34.5% | -42.4% | +67.8% | +8.1% | +50.7% | +241.6% | |
| P/FCF | 18.31 | — | — | 65.52 | 18.45 | 16.46 | — | 90.61 | — | 679.68 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | -27.7% | — | -97.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 17.88 | 29.09 | 39.74 | 43.15 | 38.35 | 32.07 | 21.54 | 41.49 | 159.08 | 79.92 | 40.57 | 113.52 | — | 1371.38 | — | — | — | — | — | — | — |
| — | -9.3% | +84.5% | +4.0% | -75.9% | -59.9% | -46.9% | -63.5% | — | -94.2% | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | 22.36 | 29.09 | 63.87 | 49.63 | 43.60 | 35.01 | 24.00 | 56.27 | 184.13 | 86.66 | 42.68 | 94.37 | — | 437.04 | — | — | — | — | — | — | — |
| — | -16.9% | +166.1% | -11.8% | -76.3% | -59.6% | -43.8% | -40.4% | — | -80.2% | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.9% | 59.6% | 58.2% | 58.1% | 58.8% | 61.4% | 61.5% | 59.2% | 55.9% | 60.5% | 61.8% | 59.0% | 61.2% | 70.0% | 69.2% | 66.0% | 70.5% | 69.9% | 76.2% | 72.3% | 70.3% |
| — | -2.9% | -5.4% | -1.9% | +5.1% | +1.4% | -0.6% | +0.3% | -8.6% | -13.6% | -10.7% | -10.5% | -13.2% | +0.1% | -9.2% | -8.7% | +0.4% | +2.2% | +11.7% | +14.2% | -1.1% | |
| Operating Margin | 17.9% | 12.5% | 7.6% | 13.2% | 16.2% | 23.2% | 19.1% | 7.1% | 3.6% | 10.9% | 12.8% | 3.2% | -42.7% | -1.7% | -5.0% | -21.6% | -21.6% | -47.5% | -59.0% | -117.2% | -218.3% |
| — | -46.2% | -60.0% | +86.2% | +349.1% | +112.3% | +49.1% | +121.6% | +108.5% | +733.7% | +355.1% | +114.8% | -97.6% | +96.4% | +91.5% | +81.6% | +90.1% | +60.7% | +36.1% | -51.6% | -235.8% | |
| Net Margin | 31.4% | 7.7% | 4.2% | 65.6% | 16.9% | 22.2% | 17.9% | 5.6% | 3.9% | 10.7% | 12.6% | 5.0% | -38.3% | -1.9% | -6.3% | -21.4% | -28.9% | -56.2% | -66.5% | -131.0% | -241.4% |
| — | -65.2% | -76.5% | +1062.7% | +336.2% | +107.9% | +42.1% | +13.5% | +110.1% | +659.1% | +298.5% | +123.2% | -32.4% | +96.6% | +90.5% | +83.7% | +88.0% | +57.0% | +40.7% | -58.4% | -236.4% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 54.2% | 2.9% | 1.5% | 25.4% | 7.2% | 11.9% | 10.4% | 3.1% | 2.1% | 7.0% | 8.2% | 3.1% | -18.7% | -0.6% | -1.4% | -3.6% | -6.2% | -20.8% | -16.5% | -17.3% | -15.5% |
| — | -75.7% | -85.4% | +713.7% | +242.5% | +71.1% | +26.2% | +2.3% | +111.3% | +1278.0% | +692.7% | +185.4% | -200.9% | +97.2% | +91.6% | +79.3% | +59.8% | -81.9% | -110.5% | -192.6% | -239.6% | |
| ROA | 20.3% | 1.0% | 0.6% | 10.5% | 2.6% | 4.0% | 3.1% | 0.9% | 0.5% | 1.6% | 1.7% | 0.6% | -3.7% | -0.2% | -0.9% | -2.4% | -3.8% | -9.6% | -8.2% | -9.5% | -9.5% |
| — | -74.9% | -81.3% | +1112.8% | +384.9% | +145.6% | +83.4% | +49.3% | +114.8% | +903.3% | +282.6% | +123.7% | +2.7% | +97.9% | +88.5% | +74.4% | +60.3% | -28.2% | -53.5% | -134.9% | -202.4% | |
| ROIC | 18.8% | 2.0% | 1.5% | 3.7% | 4.1% | 6.0% | 4.7% | 1.6% | 0.8% | 2.8% | 3.2% | 0.8% | -14.5% | -1.0% | -2.6% | -9.7% | -7.1% | -9.6% | -8.1% | -9.6% | -9.3% |
| — | -67.3% | -68.2% | +130.5% | +421.4% | +114.7% | +45.8% | +94.5% | +105.5% | +394.2% | +220.5% | +108.5% | -103.5% | +90.0% | +67.3% | -1.1% | +23.1% | -32.1% | -82.6% | -156.6% | -194.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.99 | 1.67 | 1.75 | 0.99 | 1.46 | 1.63 | 1.95 | 2.27 | 2.47 | 2.72 | 3.24 | 3.76 | 4.08 | 3.55 | 0.35 | 0.36 | 0.36 | 0.88 | 0.75 | 0.65 | 0.45 |
| — | +2.7% | -10.2% | -56.2% | -40.8% | -40.0% | -39.9% | -39.7% | -39.5% | -23.3% | +826.4% | +943.0% | +1030.9% | +301.3% | -53.7% | -44.1% | -19.2% | +125.2% | +111.7% | +93.5% | +41.6% | |
| Debt / EBITDA | 3.46 | 32.58 | 34.32 | 16.34 | 17.23 | 11.98 | 15.44 | 36.18 | 56.94 | 30.19 | 30.69 | 83.11 | — | 1059.69 | — | — | — | — | — | — | — |
| — | +171.9% | +122.3% | -54.8% | -69.7% | -60.3% | -49.7% | -56.5% | — | -97.2% | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 7.14 | 6.62 | 6.74 | 7.14 | 7.69 | 9.86 | 9.10 | 8.30 | 8.20 | 9.37 | 9.72 | 9.30 | 10.93 | 20.70 | 9.14 | 10.66 | 12.11 | 4.18 | 5.22 | 5.11 | 7.89 |
| — | -32.8% | -26.0% | -13.9% | -6.2% | +5.2% | -6.4% | -10.7% | -25.0% | -54.7% | +6.4% | -12.8% | -9.8% | +394.9% | +75.0% | +108.7% | +53.6% | -53.3% | -56.3% | -58.7% | -30.3% | |
| Quick Ratio | 6.59 | 6.07 | 6.19 | 6.59 | 7.13 | 9.17 | 8.32 | 7.52 | 7.33 | 8.48 | 8.76 | 8.49 | 10.13 | 19.74 | 8.30 | 9.79 | 11.21 | 3.41 | 4.40 | 4.47 | 6.95 |
| — | -33.8% | -25.5% | -12.3% | -2.8% | +8.2% | -5.0% | -11.4% | -27.6% | -57.1% | +5.5% | -13.3% | -9.7% | +478.2% | +88.8% | +119.1% | +61.3% | -57.8% | -59.8% | -60.6% | -32.9% | |
| Interest Coverage | 8.80 | 3.69 | 2.18 | 7.45 | 7.60 | 11.41 | 8.71 | 2.96 | 2.17 | 4.35 | 4.44 | 2.07 | -6.50 | 0.61 | -1.41 | -5.65 | -8.41 | -12.07 | -10.00 | -11.94 | -12.23 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 36 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying TMDX stock.
TransMedics Group, Inc.'s current P/E is 14.5x. The average P/E over the last 4 quarters is 54.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
TransMedics Group, Inc.'s current operating margin is 17.9%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking TransMedics Group, Inc.'s business trajectory between earnings reports.